CTOs on the Move

PRA Health Sciences

www.prahs.com

 
At PRA Health Sciences, providing innovative solutions for our clients is what we do. Side by side with our clients, we strive to move drug discovery forward, helping develop life-saving and life-improving drugs. PRA has more than 10,000 employees working in 80+ countries providing comprehensive clinical development services across all phases. From full service clinical development to the pioneering Embedded Solutions model, PRA provides a broad spectrum of solutions that meet the demands of a diverse marketplace. As a top five CRO, we have worked on 100 plus marketed drugs across several therapeutic areas and conducted the pivotal or supportive ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.prahs.com
  • 4130 Parklake Avenue Suite 400
    Raleigh, NC USA 27612
  • Phone: 919.786.8200

Executives

Name Title Contact Details
Mike Whitehead
 Associate Director, Cybersecurity Risk Management Profile
Denzil Burriss
 Director of IT Profile
Felix Ritscher
 PRA Health Sciences Profile

Similar Companies

New England Institutional Review Board NEIRB

New England Institutional Review Board NEIRB is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hobbs Medical Inc

Hobbs Medical Inc is a Stafford Springs, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PixarBio

Cofounded by Frank M. Reynolds, MIT`s Dr. Robert S. Langer, Katrin Holzhaus, and Dr. Jason Criscione, PixarBio researches and develops targeted delivery systems for drugs, cells, or biologics to treat pain, epilepsy, Parkinson`s disease, and spinal cord injury.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.

Gunn Plastic Surgery Center

Gunn Plastic Surgery Center is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.